Ranolazine — CAS 95635-55-5

Ranolazine is a high-purity Active Pharmaceutical Ingredient (API) classified under Antianginal / Late Sodium Current Inhibitor. Mediocon Inc manufactures GMP-compliant Ranolazine at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.

• Chronic stable angina pectoris
• Late sodium channel inhibition (cardioprotective)
• Reduction of angina frequency
• Adjunct therapy in coronary artery disease

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support